Quarterly report pursuant to Section 13 or 15(d)

Basic and Diluted Net Income (Loss) Per Common Share

v3.24.1.1.u2
Basic and Diluted Net Income (Loss) Per Common Share
3 Months Ended
May 05, 2024
Earnings Per Share [Abstract]  
Basic and Diluted Net Income (Loss) Per Common Share Basic and Diluted Net Income (Loss) Per Common Share
Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per common share is computed by dividing net income by the weighted average number of common shares outstanding plus dilutive potential common shares, including unvested restricted stock units, stock options, and warrants. Diluted net income per common share includes, in periods in which they are dilutive, the effect of those potentially dilutive securities under the treasury stock method, where the average market price of the common stock exceeds the exercise prices for the respective periods. In periods of loss, there are no potentially dilutive common shares to add to the weighted average number of common shares outstanding.
Thirteen weeks ended
(amounts in thousands, except per share data and share amounts) May 5,
2024
April 30,
2023
Net loss $ (12,960) $ (4,115)
Weighted-average number of common shares outstanding, basic
15,537,823  15,230,763 
Effect of dilutive securities(1)
—  — 
Weighted-average number of common shares outstanding, diluted
15,537,823  15,230,763 
Basic net income per share
$ (0.83) $ (0.27)
Diluted net income per share
$ (0.83) $ (0.27)
(1) The effect of dilutive securities includes unvested restricted stock units, stock options and warrants. For the thirteen weeks ended May 5, 2024 and April 30, 2023, unvested restricted stock units of 1,085,231 and 1,283,449, respectively, and the effects of 495,366 stock options outstanding were excluded from the computation of diluted net loss per share because their effect would have been anti-dilutive. The thirteen weeks ended April 30, 2023 also excludes the effects of 281,750 warrants since their effect would have been anti-dilutive. During fiscal 2024, all remaining outstanding warrants were exercised.